Patents by Inventor Anatoliy Melnikov

Anatoliy Melnikov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160208334
    Abstract: Provided are kits comprising biomarkers for detection of early stages (I and II) of colorectal cancer and methods for diagnosis and treatment of colorectal cancer at early stages (I and II).
    Type: Application
    Filed: September 19, 2014
    Publication date: July 21, 2016
    Applicant: US BIOMARKERS, Inc.
    Inventors: Victor V. Levenson, Anatoliy A. Melnikov
  • Patent number: 8497066
    Abstract: A DNA methylation-based test for efficiency of treatments is based on a plurality of genes. The test is suitable for monitoring treatment of subjects with neurological diseases, e.g., multiple sclerosis (MS); with cancer, e.g., breast and ovarian cancer, and with other diseases for which methylation of biomarkers differs in the diseased compared to the non-diseased state.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: July 30, 2013
    Assignee: Rush University Medical Center
    Inventors: Victor Levenson, Anatoliy Melnikov, Roumen Balabanov, Dusan Stefoski
  • Publication number: 20110190161
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods of identifying methylation patterns in genes associated with specific cancers.
    Type: Application
    Filed: April 12, 2011
    Publication date: August 4, 2011
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Anatoliy A. Melnikov, Victor V. Levenson
  • Publication number: 20100311609
    Abstract: The present invention relates to compositions and methods for diagnosing neuroinflammatory demyelinating diseases, including but not limited to, multiple sclerosis. In particular, the present invention provides methods of identifying methylation patterns in genes associated with neuroinflammatory demyelinating diseases.
    Type: Application
    Filed: August 16, 2010
    Publication date: December 9, 2010
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Anatoliy A. Melnikov, Victor V. Levenson
  • Publication number: 20100143929
    Abstract: A DNA methylation-based test for efficiency of treatments is based on a plurality of genes. The test is suitable for monitoring treatment of subjects with neurological diseases, e.g., multiple sclerosis (MS); with cancer, e.g., breast and ovarian cancer, and with other diseases for which methylation of biomarkers differs in the diseased compared to the non-diseased state.
    Type: Application
    Filed: December 4, 2009
    Publication date: June 10, 2010
    Applicant: RUSH UNIVERSITY MEDICAL CENTER
    Inventors: Victor Levenson, Anatoliy Melnikov, Roumen Balabanov, Dusan Stefoski
  • Publication number: 20080261217
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods of identifying methylation patterns in genes associated with specific cancers.
    Type: Application
    Filed: October 16, 2007
    Publication date: October 23, 2008
    Inventors: Anatoliy A. Melnikov, Victor V. Levenson
  • Publication number: 20080171338
    Abstract: The present invention relates to compositions and methods for diagnosing neuroinflammatory demyelinating diseases, including but not limited to, multiple sclerosis. In particular, the present invention provides methods of identifying methylation patterns in genes associated with neuroinflammatory demyelinating diseases.
    Type: Application
    Filed: January 14, 2008
    Publication date: July 17, 2008
    Applicant: Northwestern University
    Inventors: Anatoliy A. Melnikov, Victor V. Levenson